<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> confers increased risk for various <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Colonoscopic surveillance programs have led to reduced incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and reduced mortality from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Colonoscopy every 1-2 years beginning at age 20-25, or 10 years earlier than the first diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in a family, with annual colonoscopy after age 40, is the recommended management for mutation carriers </plain></SENT>
<SENT sid="3" pm="."><plain>Screening programs have reduced <z:hpo ids='HP_0003003'>colon cancer</z:hpo> mortality, but interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> may occur </plain></SENT>
<SENT sid="4" pm="."><plain>CASE PRESENTATION: We describe a 48-year-old woman with <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> who was found to have an <z:mpath ids='MPATH_270'>adenoma</z:mpath> with invasive <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> within one year after a <z:mpath ids='MPATH_458'>normal</z:mpath> colonoscopy </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Our patient illustrates two current concepts about <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e>: 1) <z:mpath ids='MPATH_270'>adenomas</z:mpath> are the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> precursor and 2) such <z:mpath ids='MPATH_270'>adenomas</z:mpath> may be "aggressive," in the sense that the <z:mpath ids='MPATH_270'>adenoma</z:mpath> progresses more readily and more rapidly to <z:mp ids='MP_0002038'>carcinoma</z:mp> in this setting compared to usual colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Our patient's resected <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invaded only into submucosa and <z:hpo ids='HP_0000001'>all</z:hpo> lymph nodes were negative; in that sense, she represents a success for annual colonoscopic surveillance </plain></SENT>
<SENT sid="7" pm="."><plain>Still, this case does raise the question of whether advanced imaging techniques are advisable for surveillance colonoscopy in these high-risk patients </plain></SENT>
</text></document>